Project Grant D43TW012487

Award Date 4/15/23
Completion Date 12/31/27
Dollars Obligated $1.2M
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Ghana
Similar Awards
This federal Project Grant award of $246,521, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a workforce development program to train public health and clinical research professionals in West Africa. The key products and services delivered through this grant include: Establishing a training program at the University of Sciences, Techniques and Technologies of Bamako (USTTB) in Mali...
The federal Project Grant award, titled "ANTIMICROBIAL RESISTANCE TRAINING PROGRAM IN THE TEXAS MEDICAL CENTER (AMR-TPT)", is funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $1,026,119 award to the Methodist Hospital Research Institute (HMRI) will establish a comprehensive training program to develop the next generation of scientists and clinician-scientists focused on tackling the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support a $1,553,810 research project to evaluate a genomic surveillance approach for detecting artemisinin resistance in malaria parasites in Africa. The primary awardee is the University of Maryland, Baltimore, which will collaborate with the University of Sciences, Techniques and Technologies of Bamako (Usttb) in Mali...
The federal Project Grant award with ID D43TW012726, provided by the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training), will fund a $962,344 initiative to strengthen capacity for policy-relevant life course epidemiological research in Ghana. The project aims to develop a sustainable pipeline of interdisciplinary African physician scientists and postdoctoral investigators focused on addressing the growing burden of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,303,086 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore to conduct the "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)" study. This longitudinal cohort study will evaluate the epidemiological impact of seasonal malaria chemoprevention (SMC) and the RTS,S malaria vaccine on the burden of...
This $108,916 Project Grant award from the National Institutes of Health (NIH) Fogarty International Center (CFDA 93.989 - International Research and Research Training) will allow Dr. Clifford George Banda of Kamuzu University of Health Sciences in Malawi to characterize the pharmacokinetic and safety profiles of the antimalarial drugs lumefantrine and amodiaquine in two key neglected populations: African children with severe acute malnutrition and adults living with HIV on dolutegravir-based...
The National Science Foundation (NSF) awarded a $949,997 Project Grant to Iowa State University of Science and Technology under the Biological Sciences program (CFDA 47.074) to investigate the role of environmental factors in the development of antimicrobial resistance (AMR) in municipal wastewater treatment plants. The five-year research project, starting November 1, 2023, will conduct field, laboratory, and computational studies to determine how susceptible bacterial strains are replaced by...
This $153,912 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a research study to examine the pharmacokinetics and pharmacogenomics of dolutegravir-based antiretroviral therapy in young people living with HIV in Ghana. The key objectives of the study are to: 1) Determine rates of dolutegravir-based antiretroviral therapy resistance in young people living with HIV; and 2)...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $175,000.00 to California State University, Fresno to develop a decentralized antimicrobial resistance (AMR) surveillance system in resource-limited settings. The project aims to assess the detection of drug-resistant bacteria and antimicrobial bacteriophages using cost-efficient long-read sequencing on Flongle...
The National Institute of Allergy and Infectious Diseases (NIAID), through its Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $112,943 project grant to the Jos University Teaching Hospital (JUTH) in Nigeria. The grant, titled "MICHIGAN-UNIJOS MENTORED PROGRAM FOR ENHANCED RESEARCH ADMINISTRATION (MUMPERA)", aims to build research administration capabilities and develop electronic grant management systems at JUTH and its regional partner institutions. The...

RESEARCH AND CAPACITY BUILDING IN ANTIMICROBIAL RESISTANCE IN WEST AFRICA - ABSTRACT ANTIMICROBIAL RESISTANCE (AMR) IS CONSIDERED BY THE WORLD HEALTH ORGANIZATION AS ONE OF THE GREATEST GLOBAL THREATS TO HUMAN HEALTH IN RECENT TIMES AND LIMITS ACHIEVEMENT OF SEVERAL OF THE SUSTAINABLE DEVELOPMENT GOALS, IN PARTICULAR SDG3 (ENSURE HEALTHY LIVES AND PROMOTE WELL-BEING FOR ALL AT ALL AGES). ALTHOUGH THE BURDEN OF AMR DISPROPORTIONATELY AFFECTS WESTERN SUB-SAHARAN AFRICA, RESEARCH CAPACITY IN THE SUB-REGION IS VERY LOW AND NOT WELL POSITIONED TO TACKLE THE CURRENT DEMANDS OF THE PROBLEM. THERE IS AN ACUTE SHORTAGE OF PROFESSIONALS IN WEST AFRICA IN CRUCIAL AREAS THAT ARE ESSENTIAL TO IMPACT RESEARCH, POLICY AND DISEASE CONTROL. THERE IS A DEARTH OF EXPERTISE FOR AN ARRAY OF CRUCIAL SPECIALIZATION RELEVANT TO AMR SUCH AS GENOMICS, BIOINFORMATICS AND POPULATION GENETICS COMPARED TO OTHER AFRICAN REGIONS. THESE RESEARCH CAPACITY DEFICIENCIES COULD BE ADDRESSED BY FOCUSING ON LONG-TERM INSTITUTIONAL TRAINING OF JUNIOR SCIENTISTS LOCALLY. HOWEVER, CURRENTLY, THERE ARE HARDLY ANY ACADEMIC TRAINING PROGRAMS IN WEST AFRICA COUNTRIES THAT FOCUS ON AMR. THE OBJECTIVE OF THE PROPOSED TRAINING PROGRAMME IS TO INCREASE RESEARCH INTO THE DETECTION, PREVENTION AND TREATMENT OF DRUG-RESISTANT INFECTIONS IN WEST AFRICA, EXPAND KNOWLEDGE AND SKILLS IN CLINICAL MICROBIOLOGY, AND HELP JUNIOR SCIENTISTS FIND A VIABLE CAREER PATH IN AMR RESEARCH. THE LONG-TERM GOAL IS TO ESTABLISH A CORE OF WEST AFRICAN SCIENTISTS WHO ADVANCE THE UNDERSTANDING AND MANAGEMENT OF AMR AND TO SUPPORT THEM TO BE COMPETITIVE IN OBTAINING RESEARCH GRANTS FROM INTERNATIONAL FUNDING AGENCIES SUCH AS THE NATIONAL INSTITUTES OF HEALTH, USA AND THE WELLCOME TRUST, UK.

Posted 4/30/23, 12:00 AM